Page last updated: 2024-08-23

lovastatin and Dementia

lovastatin has been researched along with Dementia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Darvesh, S; Martin, E; Rockwood, K; Walsh, R1
Imamura, A; Suzuki, Y1
Kazis, LE; Lee, A; Lee, TA; Li, NC; Wang, SW; Wolozin, B1
Feinberg, AW1

Reviews

1 review(s) available for lovastatin and Dementia

ArticleYear
[X-linked adrenoleukodystrophy (ALD)].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl

    Topics: Adrenoleukodystrophy; Age of Onset; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Biomarkers; Bone Marrow Transplantation; Chromosomes, Human, X; Dementia; Diagnosis, Differential; Drug Combinations; Erucic Acids; Fatty Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Magnetic Resonance Imaging; Male; Mutation; Phenylbutyrates; Triolein

2004

Other Studies

3 other study(ies) available for lovastatin and Dementia

ArticleYear
Differential effects of lipid-lowering agents on human cholinesterases.
    Clinical biochemistry, 2004, Volume: 37, Issue:1

    Topics: Cholinesterase Inhibitors; Clinical Trials as Topic; Cohort Studies; Dementia; Humans; Hypolipidemic Agents; Lovastatin; Molecular Structure; Pravastatin; Simvastatin

2004
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease.
    BMC medicine, 2007, Jul-19, Volume: 5

    Topics: Age Factors; Aged; Aged, 80 and over; Atorvastatin; Databases as Topic; Dementia; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lovastatin; Male; Parkinson Disease; Proportional Hazards Models; Pyrroles; Simvastatin; United States; Veterans

2007
Statins & Alzheimer's.
    Health news (Waltham, Mass.), 2000, Volume: 6, Issue:12

    Topics: Aged; Alzheimer Disease; Anticholesteremic Agents; Dementia; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Middle Aged; Pravastatin

2000